Sagent Pharmaceuticals Announces the Temporary Importation of Sodium Bicarbonate Injection, USP

January 10, 2013
Sagent Pharmaceuticals announced that due to the current critical shortage of sodium bicarbonate injection in the U.S. market, Sagent, in cooperation with the FDA, has initiated the temporary importation into the U.S. of a non-FDA approved 8.4% sodium bicarbonate injection from Phebra, an Australian manufacturer.
Yahoo! Finance